Schroder Investment Management Group Has $41.94 Million Stake in The Cooper Companies, Inc. $COO

Schroder Investment Management Group lowered its position in The Cooper Companies, Inc. (NASDAQ:COO) by 19.1% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 619,816 shares of the medical device company’s stock after selling 145,983 shares during the period. Schroder Investment Management Group’s holdings in Cooper Companies were worth $41,943,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also modified their holdings of the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in Cooper Companies by 48.9% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 22,407 shares of the medical device company’s stock valued at $1,890,000 after purchasing an additional 7,363 shares in the last quarter. Assetmark Inc. boosted its stake in Cooper Companies by 357.8% in the second quarter. Assetmark Inc. now owns 618 shares of the medical device company’s stock worth $44,000 after purchasing an additional 483 shares in the last quarter. Fox Run Management L.L.C. bought a new stake in shares of Cooper Companies during the second quarter worth $514,000. Aviva PLC grew its holdings in shares of Cooper Companies by 6.9% during the second quarter. Aviva PLC now owns 148,728 shares of the medical device company’s stock worth $10,583,000 after purchasing an additional 9,576 shares during the last quarter. Finally, Mitsubishi UFJ Asset Management Co. Ltd. increased its stake in shares of Cooper Companies by 11.1% in the second quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 383,736 shares of the medical device company’s stock valued at $27,307,000 after buying an additional 38,427 shares in the last quarter. 24.39% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In related news, Director Lawrence Erik Kurzius bought 2,000 shares of the business’s stock in a transaction on Wednesday, December 17th. The shares were purchased at an average price of $82.50 per share, with a total value of $165,000.00. Following the completion of the purchase, the director owned 7,777 shares of the company’s stock, valued at $641,602.50. This represents a 34.62% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, insider Holly R. Sheffield bought 1,230 shares of Cooper Companies stock in a transaction on Tuesday, December 16th. The shares were bought at an average price of $80.75 per share, for a total transaction of $99,322.50. Following the acquisition, the insider owned 39,052 shares of the company’s stock, valued at approximately $3,153,449. The trade was a 3.25% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders have purchased a total of 16,014 shares of company stock valued at $1,304,416 in the last ninety days. 2.08% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on COO shares. Citigroup cut their price target on Cooper Companies from $88.00 to $87.00 and set a “neutral” rating for the company in a report on Friday, March 6th. JPMorgan Chase & Co. increased their price objective on shares of Cooper Companies from $66.00 to $78.00 and gave the stock a “neutral” rating in a report on Friday, December 5th. Robert W. Baird raised their price objective on shares of Cooper Companies from $85.00 to $98.00 and gave the company an “outperform” rating in a research report on Friday, December 5th. Morgan Stanley boosted their target price on shares of Cooper Companies from $76.00 to $83.00 and gave the stock an “equal weight” rating in a research note on Monday, December 8th. Finally, Mizuho set a $100.00 target price on shares of Cooper Companies and gave the stock an “outperform” rating in a research report on Friday, December 5th. One analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, Cooper Companies presently has an average rating of “Moderate Buy” and a consensus target price of $90.79.

Cooper Companies Price Performance

COO opened at $73.75 on Thursday. The company has a fifty day moving average price of $81.66 and a two-hundred day moving average price of $76.00. The firm has a market capitalization of $14.39 billion, a PE ratio of 36.51, a P/E/G ratio of 1.92 and a beta of 1.02. The Cooper Companies, Inc. has a 52 week low of $61.78 and a 52 week high of $89.83. The company has a debt-to-equity ratio of 0.22, a quick ratio of 0.79 and a current ratio of 1.34.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings results on Thursday, March 5th. The medical device company reported $1.10 earnings per share for the quarter, beating analysts’ consensus estimates of $1.03 by $0.07. Cooper Companies had a return on equity of 10.34% and a net margin of 9.67%.The company had revenue of $1.02 billion for the quarter, compared to the consensus estimate of $1.02 billion. During the same quarter in the prior year, the business posted $0.92 EPS. The firm’s quarterly revenue was up 6.2% on a year-over-year basis. Cooper Companies has set its Q2 2026 guidance at 4.580-4.660 EPS. As a group, analysts anticipate that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

About Cooper Companies

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.